Intraoperative radiotherapy combined with postoperative concurrent chemoradiotherapy for locally advanced pancreatic cancer
10.3760/cma.j.issn.1674-6090.2012.02.016
- VernacularTitle:术中放疗联合术后同步放化疗治疗局部晚期胰腺癌
- Author:
Le WANG
;
Chengfeng WANG
;
Lixue XUAN
- Publication Type:Journal Article
- Keywords:
Pancreatic cancer;
Locally advanced;
Intraoperative radiotherapy;
Postoperative concurrent chemoradiotherapy
- From:
Journal of Endocrine Surgery
2012;06(2):124-126
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo assess the value of intraoperative radiotherapy (IORT) combined with postoperative concurrent chemoradiotherapy for locally advanced pancreatic cancer. MethodsFrom May 2008 to May 2011, 85 cases of locally advanced pancreatic cancer patients in our hospital were analyzed retrospectively.The treatment group included 40 cases treated by IORT plus drainage combined with postoperative concurrent chemoradiotherapy ( group A), and the control group included 45 undergoing IORT plus drainage ( group B).The clinical manifestation, operation plan etc.were summed up and all cases were followed up regularly to evaluate the survival time.ResultsThe follow-up time was from 6 to 15 months and the follow-up rate is 90％ (77/85).For group A and group B, the mean survival time was 10.17 ±0.58 months VS 8.05 ±0.48 months and the median survival time was 11.40 months VS 8.30 months.The survival analysis showed that group A had a significant survival advantage than group B (P =0.027 ).10 patients died in group A and 12 patients died in group B.The difference had no statistical significance (P =0.805 ).ConclusionIORT plus postoperative concurrent chemoradiotherapy can improve the survival rate of patients with locally advanced pancreatic cancer.
